Mergers & Acquisitions - Mergers & Acquisitions, Generics

Filter

Popular Filters

51 to 75 of 191 results

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

27-09-2013

The USA’s Federal Trade Commission will require Mylan and Agila Specialties to divest 11 generic injectable…

Agila SpecialitesGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaStrides Arcolab

Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market

18-09-2013

Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

Adcock Ingram agrees takeover terms with CFR

12-09-2013

Adcock Ingram (AIP: SP), one of South Africa's largest drugmakers, has provided further details of the…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Russian billionaire to acquire control of Veropharm

03-09-2013

Roman Avdeev, a well-known Russian banker and one of the country's richest people, has agreed to acquire…

GenericsMergers & AcquisitionsPharmaceuticalVeropharm

Endo Health expends $225 million on generic acquisition

29-08-2013

USA-based specialty health care company Endo Health Solutions (Nasdaq: ENDP) says that that its Qualitest…

Boca PharmacalEndo Health SolutionsGenericsMergers & AcquisitionsPharmaceutical

Akorn buys rival generic drugmaker for $640 million

27-08-2013

USA-based generics drugmaker Akorn (Nasdaq: AKRX) has bought rival generic drugmaker Hi-Tech Pharmacal…

AkornGenericsHi-Tech PharmacalMergers & AcquisitionsNorth America

Mylan's deal to acquire Strides Arcolab's unit looks set to proceed

22-08-2013

US generics and specialty drugmaker Mylan (NYSE: MYL) $1.6-billion foreign direct investment proposal…

Agila SpecialitesAsia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesRegulationStrides Arcolab

Stada Arz buys UK OTC manufacturer

21-08-2013

German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) signed and concluded a contract for…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & Ross

Fresenius Kabi sets up JV for IV generics in Indonesia

20-08-2013

Germany-based Fresenius Kabi, part of the Fresenius Group (FRE: Xetra) has formed a joint venture with…

Asia-PacificFreseniusFresenius KabiGenericsMarkets & MarketingMergers & AcquisitionsSoho Global Health

Pharmstandard agrees key terms for acquiring Singapore drugmaker

14-08-2013

Russia's largest pharma company Pharmstandard (PHST RU) - with a market capitalization of around $2 billion…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmstandard

Breckenridge to acquire certain Cypress assets

12-08-2013

Privately-held US generic drugmaker Breckenridge Pharmaceutical has entered into an agreement to acquire…

Breckenridge PharmaceuticalsCypress PharmaceuticalsGenericsMergers & AcquisitionsPernix Therapeutics

Luxembourg Haden increases its stake in Bosnia's largest drugmaker

03-08-2013

Investment firm Luxembourg Haden, which is reportedly affiliated with the well-known Russian drug distributor…

BosnalijekGenericsImperia PharmaLuxembourg HadenMergers & Acquisitions

Pfizer to separate business into three units: will this lead to spin-outs?

29-07-2013

Moving in a direction already advocated by several analysts, US pharma behemoth Pfizer (NYSE: PFE) today…

GenericsManagementMergers & AcquisitionsPfizerPharmaceutical

Elan board agrees $8.6 billion takeover bid

29-07-2013

US health care company Perrigo (NYSE: PRGO) revealed this morning that Ireland-based drugmaker Elan Corp…

ElanGenericsMergers & AcquisitionsPerrigoPharmaceuticalTysabri

Teva and Lonza to discontinue their biosimilars collaboration

25-07-2013

Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA), the world's leading generics drugmaker, and…

GenericsLonzaMergers & AcquisitionsRest of the WorldTeva Pharmaceutical Industries

Recordati acquires Tunisian drugmaker

25-07-2013

Italian drugmaker Recordati (RC: MI) has singed announces the signature of the agreements covering the…

GenericsMergers & AcquisitionsOpalia PharmaPharmaceuticalRecordati

Generics briefs: Actavis/Warner Chilcott M&A delay; Canasa patent challenge

11-07-2013

US generics major Actavis (NYSE: ACT) and Ireland-based Warner Chilcott (Nasdaq: WCRX) have each received…

ActavisAptalis PharmaCanasaGenericsLegalMergers & AcquisitionsMylan LaboratoriesNorth AmericaPatentsWarner Chilcott

Pharmstandard confirms OTC spin-off and in talks to buy Bever Pharma

10-07-2013

Russia's largest drugmaker Pharmstandard OJSC (PHST RU) has confirmed that it has initiated steps for…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmaceuticalPharmstandard

Mylan stumbles in $1.6 billion bid to take over injectables specialist Agila Specialties in India

09-07-2013

US generics and specialty drugs company Mylan (NYSE: MYL) faces a setback in its plan to acquire Indian…

Agila SpecialitesGenericsMergers & AcquisitionsMylan LaboratoriesStrides Arcolab

South Africa's Adcock Ingram confirms takeover bid from CFR Pharma

04-07-2013

In what was described as a "cautionary" statement, South Africa's largest drugmaker Adcock Ingram (AIP:…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Mayne Pharma makes second US acquisition, this time generic drugmaker Libertas

03-07-2013

In a second move into the US market in less than a year, Australia's Mayne Pharma (ASX: MYX) says it…

GenericsLibertas PharmaMayne PharmaMergers & Acquisitions

Perrigo acquires ophthalmic portfolio from Fera Pharma for initial $93 million

18-06-2013

Generic drugmaker Perrigo (NYSE: PRGO) says it has signed a definitive agreement to acquire and has completed…

Fera PharmaceuticalsGenericsMergers & AcquisitionsOphthalmicsPerrigo

Fujifilm and Dr Reddy's abandon plans for generics JV in Japan

04-06-2013

Japan's Fujifilm Corp and Indian drugmaker Dr Reddy's Laboratories (NYSE: RDY) have decided to terminate…

Dr Reddy's LaboratoriesFujifilmGenericsMergers & AcquisitionsProduction

Novo A/S acquires Norway's Xellia Pharmaceuticals in $700 million deal

21-05-2013

Denmark-based Novo A/S, the holding company of the Novo Group and the major shareholder in Novo Nordisk…

Antibiotics and Infectious diseasesGenericsMergers & AcquisitionsNovo A/SNovo NordiskPharmaceuticalXellia Pharmaceuticals

51 to 75 of 191 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top